Cancer Genomics:Integrative and Scalable Solutions in R / Bioconductor

癌症基因组学:R / Bioconductor 中的集成且可扩展的解决方案

基本信息

  • 批准号:
    9122328
  • 负责人:
  • 金额:
    $ 63.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2019-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal develops scalable R / Bioconductor software infrastructure and data resources to integrate complex, heterogeneous, and large cancer genomic experiments. The falling cost of genomic assays facilitates collection of multiple data types (e.g., gene and transcript expression, structural variation, copy number, methylation, and microRNA data) from a set of clinical specimens. Furthermore, substantial resources are now available from large consortium activities like The Cancer Genome Atlas (TCGA). Existing analysis pipelines focus on the treatment of a specific data type, leaving a critical need for tool for integrative analysis of multiple genomic assays for locally generated or publicly available data. R / Bioconductor has historically provided standardized genomic data structures and annotations that have enjoyed widespread adoption in the cancer genomics research community. This proposal adapts R / Bioconductor to meet the increasing conceptual and computational complexity of multi-assay cancer genomic experiments. We begin by developing software containers for coordinated representation, manipulation, and transformation of heterogeneous derived data from multiple cancer genomic assays. These containers are then extended to manage very large primary data resources. To facilitate integration of local experimental results with major public cancer genomics experiment data sets and annotations, we re-package public resources and provide software and cloud-based facilities for easy and fast programmatic access from within R/Bioconductor. This greatly simplifies cancer genomic analysis tasks that otherwise require significant, error-prone individual efforts. Finally, we provide software infrastructure to enable high-throughput computation using parallel and iterative approaches. The ability to manipulate multi-assay cancer genomic experiments, to understand individual experimental results in the context of public experiments and annotations, and facilities for improved high-throughput computational performance in a well-established computing environment greatly enhances opportunities for analysis and comprehension of large multi-assay cancer genomic experiments.
描述(由申请人提供):该提案开发了可扩展的R / Bioconductor软件基础设施和数据资源,以整合复杂、异质和大型癌症基因组实验。基因组测定的成本下降促进了多种数据类型的收集(例如,基因和转录本表达、结构变异、拷贝数、甲基化和微小RNA数据)。此外,大量的资源,现在可从大型财团活动,如癌症基因组图谱(TCGA)。现有的分析管道专注于处理特定的数据类型,因此迫切需要对本地生成或公开可用数据的多个基因组测定进行综合分析的工具。R / Bioconductor在历史上提供了标准化的基因组数据结构和注释,在癌症基因组学研究界得到了广泛采用。该建议适应R / Bioconductor,以满足多检测癌症基因组实验日益增加的概念和计算复杂性。我们开始通过开发软件容器协调表示,操作和转换的异构衍生数据从多个癌症基因组检测。然后扩展这些容器以管理非常大的主数据资源。为了促进本地实验结果与主要的公共癌症基因组学实验数据集和注释的整合,我们重新包装了公共资源,并提供了软件和基于云的设施,以便从R/Bioconductor内部轻松快速地进行程序访问。这大大简化了癌症基因组分析任务,否则需要大量的,容易出错的个人努力。最后,我们提供了软件基础设施,使高吞吐量计算使用并行和迭代的方法。操纵多测定癌症基因组实验、在公共实验和注释的背景下理解个体实验结果的能力,以及在完善的计算环境中用于改进的高通量计算性能的设施,极大地增强了分析和理解大型多测定癌症基因组实验的机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martin T Morgan其他文献

Martin T Morgan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martin T Morgan', 18)}}的其他基金

Cancer Genomics: Integrative and Scalable Solutions in R/Bioconductor
癌症基因组学:R/Bioconductor 中的集成且可扩展的解决方案
  • 批准号:
    10703230
  • 财政年份:
    2021
  • 资助金额:
    $ 63.29万
  • 项目类别:
Cancer Genomics: Integrative and Scalable Solutions in R/Bioconductor
癌症基因组学:R/Bioconductor 中的集成且可扩展的解决方案
  • 批准号:
    10594231
  • 财政年份:
    2021
  • 资助金额:
    $ 63.29万
  • 项目类别:
Cancer Genomics: Integrative and Scalable Solutions in R/Bioconductor
癌症基因组学:R/Bioconductor 中的集成且可扩展的解决方案
  • 批准号:
    10449603
  • 财政年份:
    2021
  • 资助金额:
    $ 63.29万
  • 项目类别:
Cancer Genomics: Integrative and Scalable Solutions in R/Bioconductor
癌症基因组学:R/Bioconductor 中的集成且可扩展的解决方案
  • 批准号:
    10478123
  • 财政年份:
    2021
  • 资助金额:
    $ 63.29万
  • 项目类别:
Cancer Genomics:Integrative and Scalable Solutions in R / Bioconductor
癌症基因组学:R / Bioconductor 中的集成且可扩展的解决方案
  • 批准号:
    9186264
  • 财政年份:
    2014
  • 资助金额:
    $ 63.29万
  • 项目类别:
Cancer Genomics:Integrative and Scalable Solutions in R / Bioconductor
癌症基因组学:R / Bioconductor 中的集成且可扩展的解决方案
  • 批准号:
    9334747
  • 财政年份:
    2014
  • 资助金额:
    $ 63.29万
  • 项目类别:
Cancer Genomics: Integrative and Salable Solutions in R/Bioconductor
癌症基因组学:R/Bioconductor 中的综合且可销售的解决方案
  • 批准号:
    10017896
  • 财政年份:
    2014
  • 资助金额:
    $ 63.29万
  • 项目类别:
Bioconductor: An Open Computing Resource for Genomics
Bioconductor:基因组学的开放计算资源
  • 批准号:
    9922952
  • 财政年份:
    2006
  • 资助金额:
    $ 63.29万
  • 项目类别:
Bioconductor: An Open Computing Resource for Genomics
Bioconductor:基因组学的开放计算资源
  • 批准号:
    8723329
  • 财政年份:
    2006
  • 资助金额:
    $ 63.29万
  • 项目类别:
Bioconductor: An Open Computing Resource for Genomics
Bioconductor:基因组学的开放计算资源
  • 批准号:
    8243004
  • 财政年份:
    2006
  • 资助金额:
    $ 63.29万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 63.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 63.29万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 63.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 63.29万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 63.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 63.29万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 63.29万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 63.29万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 63.29万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 63.29万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了